Impact of Short-term Combined Antiretroviral Therapy on Brain Virus Burden in Simian Immunodeficiency Virus-infected and CD8+ Lymphocyte-depleted Rhesus Macaques

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2010 Jul 3

PMID 20595631

Citations 17

Authors

Lakshmanan Annamalai

Veena Bhaskar

Douglas R Pauley

Heather Knight

Kenneth Williams

Margaret Lentz

Eva Ratai

Susan V Westmoreland

R Gilberto Gonzalez

Shawn P ONeil

Affiliations

Soon will be listed here.

Abstract

Antiretroviral drugs suppress virus burden in the cerebrospinal fluid of HIV-infected individuals; however, the direct effect of antiretrovirals on virus replication in brain parenchyma is poorly understood. We investigated the effect of short-term combined antiretroviral therapy (CART) on brain virus burden in rhesus monkeys using the CD8-depletion model of accelerated simian immunodeficiency virus (SIV) encephalitis. Four monkeys received CART (consisting of the nonpenetrating agents PMPA and RCV) for four weeks, beginning 28 days after SIV inoculation. Lower virus burdens were measured by real-time RT-PCR in four of four regions of brain from monkeys that received CART as compared with four SIV-infected, untreated controls; however, the difference was only significant for the frontal cortex (P < 0.05). In contrast, significantly lower virus burdens were measured in plasma and four of five lymphoid compartments from animals that received CART. Surprisingly, despite normalization of neuronal function in treated animals, the numbers of activated macrophages/microglia and the magnitude of TNF-alpha mRNA expression in brain were similar between treated animals and controls. These results suggest that short-term therapy with antiretrovirals that fail to penetrate the blood-cerebrospinal fluid barrier can reduce brain virus burden provided systemic virus burden is suppressed; however, longer treatment may be required to completely resolve encephalitic lesions and microglial activation, which may reflect the longer half-life of the principal target cells of HIV/SIV in the brain (macrophages) versus lymphoid tissues (T lymphocytes).

Citing Articles

Opioid abuse and SIV infection in non-human primates.

Deshetty U, Ray S, Singh S, Buch S, Periyasamy P J Neurovirol. 2023; 29(4):377-388.

PMID: 37418108 PMC: 10729652. DOI: 10.1007/s13365-023-01153-z.

Neuroinflammatory Profiling in SIV-Infected Chinese-Origin Rhesus Macaques on Antiretroviral Therapy.

Solis-Leal A, Siddiqui S, Wu F, Mohan M, Hu W, Doyle-Meyers L Viruses. 2022; 14(1).

PMID: 35062343 PMC: 8781366. DOI: 10.3390/v14010139.

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS.

Moretti S, Virtuoso S, Sernicola L, Farcomeni S, Maggiorella M, Borsetti A Pathogens. 2021; 10(8).

PMID: 34451482 PMC: 8398602. DOI: 10.3390/pathogens10081018.

Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.

Abreu C, Veenhuis R, Avalos C, Graham S, Parrilla D, Ferreira E mBio. 2019; 10(4).

PMID: 31431552 PMC: 6703426. DOI: 10.1128/mBio.01659-19.

Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS.

Gonzalez R, Fell R, He J, Campbell J, Burdo T, Autissier P PLoS One. 2018; 13(5):e0196949.

PMID: 29750804 PMC: 5947913. DOI: 10.1371/journal.pone.0196949.

References

Miller R, Isaacson P, Hall-Craggs M, Lucas S, Gray F, Scaravilli F . Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol. 2004; 108(1):17-23. DOI: 10.1007/s00401-004-0852-0. View

Fox H, Weed M, Huitron-Resendiz S, Baig J, Horn T, Dailey P . Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest. 2000; 106(1):37-45. PMC: 314358. DOI: 10.1172/JCI9102. View

Pierson T, McArthur J, Siliciano R . Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol. 2000; 18:665-708. DOI: 10.1146/annurev.immunol.18.1.665. View

Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, Mcarthur J . Evolution of HIV dementia with HIV infection. Int Rev Psychiatry. 2008; 20(1):25-31. DOI: 10.1080/09540260701861930. View

Chesebro B, Wehrly K, Nishio J, Perryman S . Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol. 1992; 66(11):6547-54. PMC: 240149. DOI: 10.1128/JVI.66.11.6547-6554.1992. View

Bissel S, Wang G, Trichel A, Murphey-Corb M, Wiley C . Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol. 2006; 168(5):1553-69. PMC: 1457021. DOI: 10.2353/ajpath.2006.050240. View

Orandle M, MacLean A, Sasseville V, Alvarez X, Lackner A . Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J Virol. 2002; 76(11):5797-802. PMC: 137036. DOI: 10.1128/jvi.76.11.5797-5802.2002. View

Stellbrink H, Eggers C, van Lunzen J, Albrecht H, Greten H . Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy. AIDS. 1997; 11(13):1655-7. View

Vago L, Bonetto S, Nebuloni M, Duca P, Carsana L, Zerbi P . Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies. AIDS. 2002; 16(14):1925-8. DOI: 10.1097/00002030-200209270-00009. View

10.

Seilhean D, Kobayashi K, He Y, Uchihara T, Rosenblum O, Katlama C . Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol. 1997; 93(5):508-17. DOI: 10.1007/s004010050646. View

11.

Fiala M, Looney D, Stins M, Way D, Zhang L, Gan X . TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med. 1997; 3(8):553-64. PMC: 2230176. View

12.

Williams R, Yao H, Dhillon N, Buch S . HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes. PLoS One. 2009; 4(5):e5709. PMC: 2684622. DOI: 10.1371/journal.pone.0005709. View

13.

Baskin G, Murphey-Corb M, Roberts E, Didier P, Martin L . Correlates of SIV encephalitis in rhesus monkeys. J Med Primatol. 1992; 21(2-3):59-63. View

14.

Sacktor N, Lyles R, Skolasky R, Kleeberger C, Selnes O, Miller E . HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001; 56(2):257-60. DOI: 10.1212/wnl.56.2.257. View

15.

Westmoreland S, Halpern E, Lackner A . Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J Neurovirol. 1998; 4(3):260-8. DOI: 10.3109/13550289809114527. View

16.

Albright A, Soldan S, Gonzalez-Scarano F . Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol. 2003; 9(2):222-7. DOI: 10.1080/13550280390194073. View

17.

Williams K, Hickey W . Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci. 2002; 25:537-62. DOI: 10.1146/annurev.neuro.25.112701.142822. View

18.

Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F . Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol. 2006; 11 Suppl 3:16-22. DOI: 10.1080/13550280500511741. View

19.

Wiley C, Achim C, Christopherson C, Kidane Y, Kwok S, Masliah E . HIV mediates a productive infection of the brain. AIDS. 1999; 13(15):2055-9. DOI: 10.1097/00002030-199910220-00007. View

20.

Langford T, Letendre S, Larrea G, Masliah E . Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003; 13(2):195-210. PMC: 4842209. DOI: 10.1111/j.1750-3639.2003.tb00019.x. View